# info@crystallizationsummit.com

Blog Standard

Gautam Chauhan, Cipla USA

Gautam Chauhan is a senior scientist at Cipla Ltd. dedicated to provide accessible and affordable healthcare worldwide. With a profound background in pharmaceutical research and development, he has lead...

César A. Urbina, Ph.D.

César has a Ph.D. in Green Chemistry and Catalysis from the University of St Andrews and R&D experience in multiple research universities around the globe. He co-leads business development.

Dr. Mark Cameron, J-Star Research / Porton USA

Mark obtained his Ph.D. from Manchester University, 1986-1989, under the tutelage of the renowned Organometallic Chemist Professor Brian Booth. From there he joined Merck Process Research group in the...

Dr. Alfred Lee, Merck & Co

Alfred Y. Lee is a Senior Principal Scientist in the Department of Analytical Research & Development at Merck & Co., Inc. (USA). Prior to his current position, Dr. Lee...

Dr. Daniela Blanco

Co-Founder & CEO Sunthetics, Brooklyn, NY Daniela Blanco obtained her Ph.D. in Chemical Engineering from New York University (2020) and is the co-founder and CEO of Sunthetics. At Sunthetics,...

Nirmatrelvir crystallization – process evolution from milligram to Metric ton scale through sustainability lens.

By Dr. Samir Kulkarni, Ph.D. Pfizer, Groton, CT The improved development and scaleup of Nirmatrelvir (the active 3CL protease inhibitor in PaxlovidTM) with efficient chemical synthesis led to FDA...

RSS
Follow by Email
LinkedIn
Share